310 related articles for article (PubMed ID: 35609866)
21. Effect of Antithymocyte Globulin Source on Outcomes of HLA-Matched Sibling Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Severe Aplastic Anemia.
Chen X; Wei J; Huang Y; He Y; Yang D; Zhang R; Jiang E; Ma Q; Zhai W; Yao J; Zhang G; Feng S; Han M
Biol Blood Marrow Transplant; 2018 Jan; 24(1):86-90. PubMed ID: 29032265
[TBL] [Abstract][Full Text] [Related]
22. [Outcome of allogeneic hematopoietic stem cell transplantation from HLA-matched sibling donor for 41 cases of severe aplastic anemia].
Chen X; Wei JL; Huang Y; He Y; Yang DL; Jiang EL; Ma QL; Zhou LK; Lin XT; Shen YY; Feng SZ; Han MZ
Zhonghua Xue Ye Xue Za Zhi; 2012 Aug; 33(8):610-4. PubMed ID: 23134851
[TBL] [Abstract][Full Text] [Related]
23. Prolonged use of eltrombopag in patients with severe aplastic anemia in the real world.
Li R; Wang N; Chai X; Yang L; Liu K; He H; Lin S; Yang Y; Jia J; Zhang D; Gong Y; Shi J; He G; Li J
Clin Exp Med; 2023 Oct; 23(6):2619-2627. PubMed ID: 36645546
[TBL] [Abstract][Full Text] [Related]
24. Immunosuppressive therapy versus alternative donor hematopoietic stem cell transplantation for children with severe aplastic anemia who lack an HLA-matched familial donor.
Choi YB; Yi ES; Lee JW; Sung KW; Koo HH; Yoo KH
Bone Marrow Transplant; 2017 Jan; 52(1):47-52. PubMed ID: 27668766
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of immunosuppressive therapy with or without eltrombopag in pediatric patients with acquired aplastic anemia: A Chinese retrospective study.
Fang M; Song H; Zhang J; Li S; Shen D; Tang Y
Pediatr Hematol Oncol; 2021 Oct; 38(7):633-646. PubMed ID: 33724146
[TBL] [Abstract][Full Text] [Related]
26. The oral microbiome of patients undergoing treatment for severe aplastic anemia: a pilot study.
Ames NJ; Barb JJ; Ranucci A; Kim H; Mudra SE; Cashion AK; Townsley DM; Childs R; Paster BJ; Faller LL; Wallen GR
Ann Hematol; 2019 Jun; 98(6):1351-1365. PubMed ID: 30919073
[TBL] [Abstract][Full Text] [Related]
27. T Cell-Depleted Peripheral Blood versus Unmanipulated Bone Marrow in Matched Sibling Transplantation for Aplastic Anemia.
Chorão P; Montoro J; Balaguer-Roselló A; Guerreiro M; Villalba M; Facal A; Solves P; Gómez-Segui I; Pasquini MC; Granados P; Bataller A; Louro A; de la Rubia J; Sanz MA; Sanz J
Transplant Cell Ther; 2023 May; 29(5):322.e1-322.e5. PubMed ID: 36682469
[TBL] [Abstract][Full Text] [Related]
28. Comparison of frontline treatment with intensive immunosuppression therapy and HLA-haploidentical hematopoietic stem cell transplantation for young patients with severe aplastic anemia - A meta analysis.
Geng C; Liu X; Chen M; Yang C; Han B
Leuk Res; 2020 Jan; 88():106266. PubMed ID: 31743865
[TBL] [Abstract][Full Text] [Related]
29. [Efficacy and safety of allogeneic hematopoietic stem cell transplantation in the treatment of 28 patients with hepatitis-related aplastic anemia].
Wang Y; Li J; Pang AM; Yang DL; Chen X; Zhang RL; Wei JL; Ma QL; Zhai WH; He Y; Jiang EL; Han MZ; Feng SZ
Zhonghua Xue Ye Xue Za Zhi; 2023 Aug; 44(8):628-634. PubMed ID: 37803835
[No Abstract] [Full Text] [Related]
30. Partial SAA patients benefit from delayed response of IST.
Wang T; Wang C; Liu C; Shao Z; Fu R
Front Immunol; 2023; 14():1067977. PubMed ID: 36845107
[TBL] [Abstract][Full Text] [Related]
31. Allo-HSCT compared with immunosuppressive therapy for acquired aplastic anemia: a system review and meta-analysis.
Zhu Y; Gao Q; Hu J; Liu X; Guan D; Zhang F
BMC Immunol; 2020 Mar; 21(1):10. PubMed ID: 32138642
[TBL] [Abstract][Full Text] [Related]
32. Eltrombopag as frontline treatment of aplastic anaemia in routine practice: implications on cost and efficacy.
Hwang YY; Chan TSY; Chan FHY; Lau CWP; Luk YY; Lau GWN; Chan KP; Leung KH; Kho B; Lau JSM; Lau CK; Mak V; Yip SF; Lin SY; Sim JPY; Kwong YL
Ann Hematol; 2022 Jun; 101(6):1163-1172. PubMed ID: 35412083
[TBL] [Abstract][Full Text] [Related]
33. Addition of eltrombopag to immunosuppressive therapy in patients with newly diagnosed aplastic anemia.
Assi R; Garcia-Manero G; Ravandi F; Borthakur G; Daver NG; Jabbour E; Burger J; Estrov Z; Dinardo CD; Alvarado Y; Hendrickson S; Ferrajoli A; Wierda W; Cortes J; Kantarjian H; Kadia TM
Cancer; 2018 Nov; 124(21):4192-4201. PubMed ID: 30307606
[TBL] [Abstract][Full Text] [Related]
34. Haploidentical hematopoietic stem cell transplantation as a first-line treatment for paediatric severe aplastic anemia: a single-center research.
Yuan M; Jia C; Ma J; Zhang M; Zhu G; Wang B; Zheng J; Qin M; Wu R; Li S
Int J Med Sci; 2024; 21(6):1027-1036. PubMed ID: 38774762
[TBL] [Abstract][Full Text] [Related]
35. Novel therapeutic choices in immune aplastic anemia.
Scheinberg P
F1000Res; 2020; 9():. PubMed ID: 32953089
[TBL] [Abstract][Full Text] [Related]
36. The role of donor type and pre-transplant immunosuppression on outcomes of hematopoietic stem cell transplantation in children and young adults with severe aplastic anemia.
Kashif R; Horn B; Milner J; Joyce M; Dalal M; Lee JJ; McNerney K; Cline J; Fort J; Castillo P; Galvez J; Alperstein W; Ligon J; Ziga E; Crawford D; Chellapandian D
Pediatr Transplant; 2024 Jun; 28(4):e14784. PubMed ID: 38766976
[TBL] [Abstract][Full Text] [Related]
37. Long-term outcomes in patients with severe aplastic anemia treated with immunosuppression and eltrombopag: a phase 2 study.
Patel BA; Groarke EM; Lotter J; Shalhoub R; Gutierrez-Rodrigues F; Rios O; Quinones Raffo D; Wu CO; Young NS
Blood; 2022 Jan; 139(1):34-43. PubMed ID: 34525188
[TBL] [Abstract][Full Text] [Related]
38. Burden of illness among patients with severe aplastic anemia who have had insufficient response to immunosuppressive therapy: a multicenter retrospective chart review study.
Peffault de Latour R; Huynh L; Ivanova JI; Totev T; Bilginsoy M; Antin J; Roy A; Duh MS
Ann Hematol; 2020 Apr; 99(4):743-752. PubMed ID: 32065291
[TBL] [Abstract][Full Text] [Related]
39. Outcome of aplastic anaemia in children. A study by the severe aplastic anaemia and paediatric disease working parties of the European group blood and bone marrow transplant.
Dufour C; Pillon M; Sociè G; Rovò A; Carraro E; Bacigalupo A; Oneto R; Passweg J; Risitano A; Tichelli A; Peffault de Latour R; Schrezenmeier H; Hocshmann B; Peters C; Kulasekararaj A; Van Biezen A; Samarasinghe S; Hussein AA; Ayas M; Aljurf M; Marsh J
Br J Haematol; 2015 May; 169(4):565-73. PubMed ID: 25683884
[TBL] [Abstract][Full Text] [Related]
40. Haploidentical haematopoietic stem cell transplantation for the treatment of severe aplastic anaemia patients with high-risk factors who lack an HLA-matched sibling donor.
Niu YY; Ma LM; Wang T
Transfus Clin Biol; 2022 Feb; 29(1):53-59. PubMed ID: 34343707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
